NO.1 PHARMACY released its performance for the first half of the year, with a net profit attributable to the parent company of 14.0242 million yuan, a decrease of 89.19%
I'm PortAI, I can summarize articles.
NO.1 PHARMACY released its 2025 semi-annual report, with operating revenue of 997 million yuan, a year-on-year increase of 11.58%. The net profit attributable to the parent company was 14.0242 million yuan, a year-on-year decrease of 89.19%. The net profit after deducting non-recurring gains and losses was 9.012 million yuan, a year-on-year increase of 24.58%. The basic earnings per share were 0.0629 yuan. The company achieved operational returns through the expansion of innovative businesses and cost reduction and efficiency improvement
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments